Tumor-Infiltrating Lymphocytes and Adoptive Cell Therapy: State of the Art in Colorectal, Breast and Lung Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-Infiltrating Lymphocytes and Adoptive Cell Therapy: State of the Art in Colorectal, Breast and Lung Cancer
Authors
Keywords
-
Journal
PHYSIOLOGICAL RESEARCH
Volume 72, Issue S3, Pages S209-S224
Publisher
Institute of Physiology of the Czech Academy of Sciences
Online
2023-10-25
DOI
10.33549/physiolres.935155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden
- (2023) Jitske van den Bulk et al. Journal for ImmunoTherapy of Cancer
- Combinatory statuses of tumor stromal percentage and tumor infiltrating lymphocytes as prognostic factors in stage III colorectal cancers
- (2022) Hye‐Yeong Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions
- (2022) Joachim Stoltenborg Granhøj et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Neoantigen-Specific T Cells in Adoptive Cell Therapy
- (2022) Eric Tran CANCER JOURNAL
- Potential biomarkers: Identifying powerful tumor specific T cells in adoptive cellular therapy
- (2022) Wu Ge et al. Frontiers in Immunology
- Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition
- (2021) Anders H. Kverneland et al. CYTOTHERAPY
- Intra-tumoral CD39+CD8+ T cells predict response to PD-1/PD-L1 blockade in patients with NSCLC
- (2021) Joe Yeong et al. Journal of Thoracic Oncology
- Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
- (2021) Shuyang S. Qin et al. Cells
- Transcriptomic signatures of tumors undergoing T cell attack
- (2021) Aishwarya Gokuldass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Systematic analysis of CD39, CD103, CD137, and PD‐1 as biomarkers for naturally occurring tumor antigen‐specific TILs
- (2021) Monika A. Eiva et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD39 Regulation and Functions in T Cells
- (2021) Eleonora Timperi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities
- (2021) Davood Bashash et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade
- (2021) Ines Malenica et al. Nature Communications
- Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer
- (2021) Amrendra Kumar et al. Frontiers in Immunology
- DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer
- (2021) Qi Zou et al. Journal for ImmunoTherapy of Cancer
- M2-Type Macrophages Induce Tregs Generation by Activating the TGF-β/Smad Signalling Pathway to Promote Colorectal Cancer Development
- (2021) Xueqian Ma et al. OncoTargets and Therapy
- Author Correction: Single-cell profiling defines the prognostic benefit of CD39high tissue resident memory CD8+ T cells in luminal-like breast cancer
- (2021) Agnese Losurdo et al. Communications Biology
- Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
- (2020) Emilie Picard et al. Frontiers in Immunology
- Relationship between T cell receptor clonotype and PD‐1 expression of tumor‐infiltrating lymphocytes in colorectal cancer
- (2020) Kenta Sukegawa et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer
- (2020) Mara Kitsou et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Adoptive T Cell Therapy with IL-12–Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity
- (2020) Christopher G. Tucker et al. JOURNAL OF IMMUNOLOGY
- Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer
- (2020) Anders Handrup Kverneland et al. Oncotarget
- IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer
- (2020) Scott N. Furlan et al. Blood Advances
- Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response
- (2020) Fei-Fei Hu et al. BRIEFINGS IN BIOINFORMATICS
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer
- (2019) Mary L. Disis et al. JAMA Oncology
- Tissue-Resident T Cells and Other Resident Leukocytes
- (2019) David Masopust et al. Annual Review of Immunology
- Prognostic Impact of Tumor-Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer
- (2019) Joseph C. Kong et al. DISEASES OF THE COLON & RECTUM
- Tumor-Infiltrating Lymphocytes in the Checkpoint Inhibitor Era
- (2019) Gerald P. Linette et al. Current Hematologic Malignancy Reports
- Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
- (2019) U Dafni et al. ANNALS OF ONCOLOGY
- Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
- (2019) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Signaling and Function of Interleukin-2 in T Lymphocytes
- (2018) Sarah H. Ross et al. Annual Review of Immunology
- Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patients
- (2018) Ronny Ben-Avi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study
- (2018) Magnus Pedersen et al. OncoImmunology
- A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus-associated epithelial cancers
- (2018) Sanja Stevanovic et al. CLINICAL CANCER RESEARCH
- Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma
- (2018) Wei Ding et al. MEDICINE
- Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
- (2018) Wouter Scheper et al. NATURE MEDICINE
- Adoptive cellular therapies: the current landscape
- (2018) Maartje W. Rohaan et al. VIRCHOWS ARCHIV
- Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
- (2018) Maartje W. Rohaan et al. Journal for ImmunoTherapy of Cancer
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- 4-1BB–Enhanced Expansion of CD8 + TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8 + T Cells
- (2017) Michiko Harao et al. Cancer Immunology Research
- A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes
- (2017) Marie-Andrée Forget et al. Frontiers in Immunology
- Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
- (2017) Sivan Seliktar-Ofir et al. Frontiers in Immunology
- Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
- (2017) Mirjana Efremova et al. Frontiers in Immunology
- Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2 + T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate
- (2016) Nicholas A. Zumwalde et al. Cancer Prevention Research
- Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
- (2016) Maria Parkhurst et al. CLINICAL CANCER RESEARCH
- Rationale for anti-CD137 cancer immunotherapy
- (2016) Amani Makkouk et al. EUROPEAN JOURNAL OF CANCER
- PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes
- (2016) Matthew W Rosenbaum et al. MODERN PATHOLOGY
- Emerging concepts of T cell metabolism as a target of immunotherapy
- (2016) Chih-Hao Chang et al. NATURE IMMUNOLOGY
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer
- (2016) Dong-Qiang Zeng et al. Oncotarget
- Characterization of the T-cell receptor beta chain repertoire in tumor-infiltrating lymphocytes
- (2016) Katsumi Nakanishi et al. Cancer Medicine
- Role of IL-2 in cancer immunotherapy
- (2016) Tao Jiang et al. OncoImmunology
- Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
- (2016) Joseph McLaughlin et al. JAMA Oncology
- Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes
- (2016) Sasha E. Stanton et al. JAMA Oncology
- Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials
- (2015) M. V. Dieci et al. ANNALS OF ONCOLOGY
- Tumor-Infiltrating Lymphocyte Therapy
- (2015) Laszlo G. Radvanyi CANCER JOURNAL
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
- (2015) Bo Wang et al. JOURNAL OF UROLOGY
- Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7R Dependent
- (2015) C. B. Johnson et al. Cancer Immunology Research
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- The intratumoural subsite and relation of CD8+ and FOXP3+ T lymphocytes in colorectal cancer provide important prognostic clues
- (2014) A Ling et al. BRITISH JOURNAL OF CANCER
- Abstract S1-07: Prognostic value of tumor-infiltrating lymphocytes (TILs) in two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199:
- (2014) S Adams et al. CANCER RESEARCH
- Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
- (2014) Y.-C. Lu et al. CLINICAL CANCER RESEARCH
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis
- (2014) Yong Huang et al. PLoS One
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities
- (2014) Magdalena Kovacsovics-Bankowski et al. Journal for ImmunoTherapy of Cancer
- Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
- (2012) Eva Ellebaek et al. Journal of Translational Medicine
- CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
- (2011) Fangfang Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Leukocyte composition of human breast cancer
- (2011) B. Ruffell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
- (2010) M. E. Dudley et al. CLINICAL CANCER RESEARCH
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
- (2010) Takashi Inozume et al. JOURNAL OF IMMUNOTHERAPY
- Cancer related inflammation: The macrophage connection
- (2008) Antonio Sica et al. CANCER LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now